Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Cognetix
Cognetix explored the use of snail toxins for the treatment of epilepsy, pain and anesthesia.
Cognetix
Salt Lake City, UT
